6,855 Shares in Danaher Corporation $DHR Acquired by Machina Capital S.A.S.

Machina Capital S.A.S. bought a new stake in shares of Danaher Corporation (NYSE:DHR) in the 3rd quarter, Holdings Channel.com reports. The institutional investor bought 6,855 shares of the conglomerate’s stock, valued at approximately $1,519,000.

A number of other institutional investors and hedge funds have also made changes to their positions in DHR. Main Street Group LTD bought a new stake in Danaher in the first quarter valued at $25,000. N.E.W. Advisory Services LLC acquired a new stake in shares of Danaher in the 2nd quarter worth about $25,000. Marquette Asset Management LLC increased its holdings in shares of Danaher by 192.1% in the 3rd quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 73 shares during the period. Field & Main Bank bought a new stake in Danaher in the 2nd quarter valued at about $29,000. Finally, Solstein Capital LLC bought a new stake in Danaher in the 2nd quarter valued at about $33,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP Gregory M. Milosevich sold 2,100 shares of the firm’s stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $230.62, for a total transaction of $484,302.00. Following the completion of the transaction, the executive vice president owned 22,367 shares in the company, valued at approximately $5,158,277.54. This trade represents a 8.58% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CAO Christopher Bouda sold 7,598 shares of Danaher stock in a transaction that occurred on Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the transaction, the chief accounting officer directly owned 9,107 shares in the company, valued at $2,136,137.92. This represents a 45.48% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 10.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. TD Cowen boosted their target price on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research note on Thursday, October 22nd. Barclays raised their price target on shares of Danaher from $255.00 to $260.00 and gave the company an “overweight” rating in a research note on Thursday, October 22nd. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research note on Monday, October 26th. Citigroup lifted their price target on Danaher from $230.00 to $270.00 and gave the company a “buy” rating in a report on Thursday, October 22nd. Finally, Guggenheim boosted their price objective on Danaher from $200.00 to $250.00 and gave the stock a “buy” rating in a research report on Thursday, October 1st. Eighteen analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $242.91.

Danaher Price Performance

Shares of DHR opened at $232.08 on Friday. The firm has a market capitalization of $163.28 billion, a price-to-earnings ratio of 37.98, a price-to-earnings-growth ratio of 2.95 and a beta of 0.76. The stock’s fifty day moving average is $222.11 and its 200-day moving average is $201.53. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, topping analysts’ consensus estimates of $1.92 by $0.19. The company had revenue of $6.55 billion for the quarter, compared to the consensus estimate of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. Danaher’s revenue was up 8.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.89 EPS. Equities analysts anticipate that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is presently 26.19%.

Danaher Company Profile

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.